CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study.
Cancer
; 129(5): 697-713, 2023 03 01.
Article
in En
| MEDLINE
| ID: mdl-36572991
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ovarian Neoplasms
/
Carcinoma
/
Cystadenocarcinoma, Serous
Limits:
Female
/
Humans
Language:
En
Journal:
Cancer
Year:
2023
Type:
Article
Affiliation country:
Canada